Clinical Trial Update: FMT in Obesity: RYGB vs. LEAN vs. Autologous FMT [NA]

View source ↗

Summary

A clinical trial comparing fecal microbiota transplant (FMT) strategies for obesity and metabolic syndrome is currently recruiting, including Roux-en-Y gastric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Insulin Resistance
• Metabolic Syndrome
• Obesity
• Prediabetes

Drugs mentioned

• Fecal microbiota transplant (FMT) (fecal microbiota transplantation)

Snippet

Sponsor: Wiebke Kristin Fenske | Conditions: Morbid Obesity, Metabolic Syndrome | NA | Status: RECRUITING